Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting

  • James H. A. Clubb
  • , Tatiana V. Kudling
  • , Mykhailo Girych
  • , Lyna Haybout
  • , Santeri Pakola
  • , Firas Hamdan
  • , Víctor Cervera-Carrascon
  • , Annabrita Hemmes
  • , Susanna Grönberg-Vähä-Koskela
  • , João Manuel Santos
  • , Dafne C. A. Quixabeira
  • , Saru Basnet
  • , Camilla Heiniö
  • , Victor Arias
  • , Elise Jirovec
  • , Shreyas Kaptan
  • , Riikka Havunen
  • , Suvi Sorsa
  • , Abdullah Erikat
  • , Joel Schwartz
    • Marjukka Anttila, Katri Aro, Tapani Viitala, Ilpo Vattulainen, Vincenzo Cerullo, Anna Kanerva, Akseli Hemminki

Research output: Contribution to journal › Article › Scientific › peer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting'. Together they form a unique fingerprint.

Keyphrases

INIS

Immunology and Microbiology